HEALWELL AI Names Ian Kidson as New Board Member
Appointment of Ian Kidson: HEALWELL AI Inc. has appointed Ian Kidson to its Board of Directors, bringing extensive experience in financial governance and healthcare leadership to support the company's mission of improving healthcare through early disease detection.
Ian Kidson's Background: Kidson has a distinguished career in both private and public sectors, having served as CFO for various companies, including Docebo Inc. and Apollo Health Corp., and held senior roles in capital markets.
HEALWELL's Mission: The company focuses on preventative care, aiming to enhance healthcare and save lives by developing advanced clinical decision support systems for early identification of diseases.
Company Overview: HEALWELL AI is publicly traded on the Toronto Stock Exchange and the OTC Exchange, and is dedicated to improving patient health outcomes through innovative technology and clinical capabilities.
Trade with 70% Backtested Accuracy
Analyst Views on DCBO
About DCBO
About the author

- Management Presentation Schedule: Docebo Inc. will present at several investor and software industry conferences in April and May 2026, with the first event being the Docebo Inspire Investor Briefing on April 21 in Miami, expected to attract significant investor interest.
- Industry Impact: At the 21st Annual Needham Technology, Media, & Consumer Conference on May 12, Docebo will showcase its leadership in the AI workforce readiness platform space, further solidifying its influence in the industry.
- Technology Innovation Showcase: On May 21, Docebo will present its latest technological advancements at the CIBC Technology & Innovation Conference in Toronto, aiming to attract potential clients and partners by demonstrating its AI-driven solutions.
- Webcast Availability: All public presentations will be webcast, allowing investors to access more information on Docebo's investor relations website under the
- Buyback Overview: Docebo announced a substantial issuer bid to repurchase up to $60 million of its common shares at $20.40 per share, indicating strong confidence in its stock value.
- Subscription Details: The offer saw a total of 3,810,842 common shares tendered, with the expected repurchase representing approximately 10.2% of the outstanding shares as of February 1, 2026, reflecting positive investor sentiment towards the company.
- Major Shareholder Impact: Following the buyback, Intercap Inc. is expected to own 61.6% of the company, reinforcing its controlling position, with 372,612 shares acquired under the offer further solidifying its shareholder rights.
- Future Outlook: While the exact number of shares to be purchased is subject to verification, the company's optimistic outlook suggests ongoing growth potential in the AI workforce readiness platform sector.
- Share Increase: Long Path Partners LP disclosed a purchase of 572,292 shares of Alkami Technology in Q4 2025, bringing its total stake to $72.5 million, an increase of $8.6 million from the previous quarter, indicating strong confidence in the company's long-term value.
- Portfolio Concentration: Following this purchase, Alkami accounted for approximately 25% of Long Path's assets under management, highlighting the fund's focus on Alkami, which is one of only seven U.S.-listed stocks in its concentrated portfolio.
- Market Performance Analysis: As of February 13, 2026, Alkami's stock traded at $16.27, down 50.4% over the past year and underperforming the S&P 500 by 62.2 percentage points, reflecting market concerns over its short-term volatility.
- Long-Term Growth Potential: Despite short-term challenges, Alkami's revenue grew by 33% in 2025, and the company is gaining traction in sales of its AI-powered solutions, indicating significant long-term growth potential in the digital banking transformation.
- Earnings Growth: Docebo Inc. reported fourth-quarter earnings of $26.85 million, translating to $0.91 per share, a significant increase from last year's $11.91 million and $0.38 per share, indicating strong market performance and enhanced profitability.
- Adjusted Earnings: Excluding items, Docebo's adjusted earnings stood at $13.26 million, or $0.45 per share, demonstrating the company's success in cost control and operational efficiency improvements.
- Revenue Increase: The company's revenue rose by 10.5% year-over-year to $63.03 million, up from $57.04 million last year, reflecting sustained demand for its products and services in the market.
- Future Guidance: Docebo's revenue guidance for the next quarter is set between $63.5 million and $63.7 million, showcasing the company's confidence in future growth and providing a positive outlook for investors.
- Strong Earnings: Docebo reported a Q4 GAAP EPS of $0.91, exceeding expectations by $0.61, indicating a significant improvement in profitability and enhancing its competitive position in the market.
- Revenue Growth: The company achieved Q4 revenue of $63.04 million, reflecting a 10.5% year-over-year increase and surpassing market expectations by $0.42 million, showcasing success in customer acquisition and market expansion.
- Future Guidance: For fiscal year 2026, Docebo projects subscription revenue between $251.5 million and $253.5 million, with total revenue expected between $267.5 million and $269.5 million, demonstrating confidence in future growth prospects.
- Adjusted EBITDA: The anticipated adjusted EBITDA for 2026 is between $52.5 million and $54.5 million, indicating effective strategies in cost control and profitability enhancement.
- Earnings Announcement: Docebo is set to release its Q4 earnings on February 27 before market open, with a consensus EPS estimate of $0.36, reflecting a robust 28.6% year-over-year growth, indicating sustained profitability.
- Revenue Growth Expectations: The anticipated revenue for Q4 stands at $62.62 million, representing a 9.8% year-over-year increase, showcasing Docebo's positive performance in market demand and customer base expansion, further solidifying its industry position.
- Consistent Outperformance: Over the past two years, Docebo has consistently beaten EPS and revenue estimates 100% of the time, enhancing investor confidence and demonstrating the company's exceptional financial management and market forecasting capabilities.
- Upward Revision Trends: In the last three months, EPS estimates have seen two upward revisions, while revenue estimates have experienced seven upward revisions, reflecting analysts' optimistic outlook on the company's future growth, potentially attracting more investor interest.









